Cargando…
Population Carrier Rates of Pathogenic ARSA Gene Mutations: Is Metachromatic Leukodystrophy Underdiagnosed?
BACKGROUND: Metachromatic leukodystrophy (MLD) is a severe neurometabolic disease caused mainly by deficiency of arylsulfatase A encoded by the ARSA gene. Based on epidemiological surveys the incidence of MLD per 100 000 live births varied from 0.6 to 2.5. Our purpose was to estimate the birth preva...
Autores principales: | Ługowska, Agnieszka, Ponińska, Joanna, Krajewski, Paweł, Broda, Grażyna, Płoski, Rafał |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112151/ https://www.ncbi.nlm.nih.gov/pubmed/21695197 http://dx.doi.org/10.1371/journal.pone.0020218 |
Ejemplares similares
-
Identification of Novel ARSA Mutations in Chinese Patients with Metachromatic Leukodystrophy
por: Chen, Li, et al.
Publicado: (2018) -
Identification of a missense ARSA mutation in metachromatic leukodystrophy and its potential pathogenic mechanism
por: Guo, Liyuan, et al.
Publicado: (2020) -
A closer look at ARSA activity in a patient with metachromatic leukodystrophy
por: Doherty, Kathleen, et al.
Publicado: (2019) -
Metachromatic leukodystrophy genotypes in The Netherlands reveal novel pathogenic ARSA variants in non-Caucasian patients
por: Beerepoot, Shanice, et al.
Publicado: (2020) -
An arylsulphatase A (ARSA) frameshift mutation (289insG) in metachromatic leukodystrophy (MLD)
por: Perkins, Kelly J, et al.
Publicado: (2005)